Rankings
▼
Calendar
CPRX Q1 2016 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
CPRX
Catalyst Pharmaceuticals, Inc.
$3B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$6M
Net Income
-$5M
EPS (Diluted)
$-0.07
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$457,969
Balance Sheet
Total Assets
$54M
Total Liabilities
$3M
Stockholders' Equity
$51M
Cash & Equivalents
$22M
← FY 2016
All Quarters
Q2 2016 →